Hospital Delivery Charges Significantly Higher When Babies Conceived Through Assisted Reproductive Technologies
By Miriam Zoll,
Reporting on Health
| 03. 04. 2014
A new study published in the Journal of Perinatology [1] online has found that from 2009-2011 in California, hospital delivery charges associated with babies born through assisted reproductive technologies (ART) or artificial insemination (AI) were significantly higher than charges for babies born through natural conception –– in some cases exceeding $1.2 million per infant.
The retrospective study was based on 2009-2011 data from the California Office of Statewide Health Planning and Development and conducted by researchers from the Loma Linda University School of Medicine.
In 2011, statewide average hospital charges for maternity care for women who delivered ART/AI infants were almost fifty percent higher than fees for non-ART infants born late preterm or at term––$35,768 compared to $18,654. The higher charges are linked to a 24- to 27-fold increase across California of multiple births, and significantly higher rates of preterm births, lower birth weights, fetal anomalies and stillbirth, among infants born through ART/AI. In 2009, there were 5,710 ART/AI live births in California and 1,718 of these births -- or 30.1 percent –– were multiple births consisting of twins, triplets...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
